I am an organiser of a leukemia patient group. How do I become member of CML Advocates?

I am a Leukemia Patient Group Organiser. How do I become a member of the CML Advocates Network?

Please note that only advocates (representatives of leukemia patient organisations) can become members of the network and access this member-only area of the website. This is because we want to keep our discussions on advocacy and campaigning confidential within the patient community.

To register as a member of the CML Advocates Network:
  • go to the homepage and click on "No account yet? Register".
  • please fill in the form providing details of yourself and your organisation.
  • remember to provide a brief description of your organisation.
  • be sure to tick the box title 'Accept terms and conditions'.
  • click on 'Send'
The moderators will then verify the information you have provided within 1-2 working days. If you are eligible, you will receive an email welcoming you as a member of the CML Advocates Network. You will also be granted access to the member-only area then.

Membership is free of charge.

The member-only area of the CML Advocates Network offers the following:
  • An advocacy knowledge base (e.g. on patient advocacy and leukemia background information)
    • CML therapies
    • Approved drugs
    • Drugs close to approval
    • New drugs in early stage research and/or trials
    • Novel combination therapies
    • Transplantation: including both traditional and new techniques
  • A discussion forum to discuss online with other CML advocates.
  • A download area, e.g. for conference material, presentations, and tools.
  • a CML Event Calendar, providing details of upcoming specialist haematology meetings including those of ASH, EHA, ASCO, EBMT, Leukemia Net and other relevant CML conferences.

Please donate!

Please donate!

Tweet Feed

CML Advocates Network with the Rare Disease Day 2018… @cmlnet

Retweeted Wednesday, 21 February 2018

@SamanthaNier @EHA_Hematology Very happy to meet you there, Samantha! #EHA23 #patient #advocacy #cml #leukemia

Wednesday, 21 February 2018 in reply to SamanthaNier